MyFinsight
Home
Blog
About
Net income
$37,822K
(-38.12%↓ Y/Y)
Accounts payable
$10,079K
(7.12%↑ Y/Y)
Stock-based compensation
$6,135K
(-36.01%↓ Y/Y)
Depreciation and
amortization
$1,781K
(-55.77%↓ Y/Y)
Prepaid expenses and
other current assets
-$420K
(-120.05%↓ Y/Y)
Amortization of debt discount
$192K
(-45.14%↓ Y/Y)
Deferred income tax
provision
$3K
(-99.94%↓ Y/Y)
Net cash provided by
operating activities
$29,539K
(1917.69%↑ Y/Y)
Canceled cashflow
$26,893K
Net increase
(decrease) in cash and cash...
-$2,133K
(83.42%↑ Y/Y)
Canceled cashflow
$29,539K
Revolving facility
proceeds-JPMCredit Facilities
$125,000K
Net proceeds from
the exercise of...
$35K
(-98.38%↓ Y/Y)
Inventories
$17,215K
(-18.91%↓ Y/Y)
Accrued expenses
-$6,583K
(-26.45%↓ Y/Y)
Accounts receivable
$2,369K
(-96.03%↓ Y/Y)
Deposits and other assets
$401K
(31.05%↑ Y/Y)
Other current and
non-current liabilities
-$290K
(51.83%↑ Y/Y)
Amortization of license
revenue
-$35K
(50.70%↑ Y/Y)
Net cash used in
financing activities
-$29,416K
(-315.54%↓ Y/Y)
Canceled cashflow
$125,035K
Net cash provided by
(used in) investing...
-$2,256K
(68.87%↑ Y/Y)
something is missing
-$125,000K
Acquisition of treasury
stock
$25,054K
Taxes paid on vested
restricted stock units
$3,928K
(-53.34%↓ Y/Y)
Term loan
payments-JPMCredit Facilities
$469K
Purchase of property and
equipment
$2,256K
(-68.33%↓ Y/Y)
Back
Back
Cash Flow
ADMA logo-svg
ADMA BIOLOGICS, INC. (ADMA)
ADMA logo-svg
ADMA BIOLOGICS, INC. (ADMA)
source: myfinsight.com